Glycosaminoglycans of amniotic fluid consist of hyluronic acid and chondroitin sulphate.
High concentrations of glycoproteins are excreted in fetus affected with MPS.
The study established normative data for MPS at 16-22 weeks gestation.
It is a useful screening test in advanced pregnancies for a quick recognition of MPS.